CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,032 | -71.7% | 28,800 | -70.1% | 0.00% | – |
| Q2 2023 | $141,448 | +284.3% | 96,223 | +331.4% | 0.00% | – |
| Q1 2023 | $36,807 | -11.8% | 22,307 | -25.2% | 0.00% | – |
| Q4 2022 | $41,742 | -91.7% | 29,816 | -90.9% | 0.00% | – |
| Q3 2022 | $503,000 | +17.8% | 327,160 | +68.6% | 0.00% | – |
| Q2 2022 | $427,000 | -75.0% | 194,097 | -71.8% | 0.00% | – |
| Q1 2022 | $1,705,000 | -1.2% | 687,677 | +139.7% | 0.00% | – |
| Q4 2021 | $1,725,000 | -73.6% | 286,923 | -70.8% | 0.00% | -100.0% |
| Q3 2021 | $6,540,000 | -22.8% | 982,148 | -22.9% | 0.00% | -50.0% |
| Q2 2021 | $8,469,000 | -38.4% | 1,273,650 | -14.2% | 0.00% | -33.3% |
| Q1 2021 | $13,750,000 | -25.9% | 1,484,966 | +44.1% | 0.00% | -25.0% |
| Q4 2020 | $18,544,000 | +358.7% | 1,030,765 | +261.8% | 0.00% | +300.0% |
| Q3 2020 | $4,043,000 | – | 284,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |